- 1) Sandhoff, K., and Kolter, T., Biosynthesis and degradation of mammalian glycosphingolipids. Philos. Trans. R. Soc. Lond. B Biol. Sci., 358, 847–861 (2003).
- 2) Merrill, A. H., Ceramide: a new lipid “second messenger”? Nutr. Rev., 50, 78–80 (1992).
- 3) Hakomori, S. I., Cell adhesion/recognition and signal transduction through glycosphingolipid microdomain. Glycoconj. J., 17, 143–151 (2000).
- 4) Proia, R. L., Glycosphingolipid functions: insights from engineered mouse models. Philos. Trans. R. Soc. Lond. B Biol. Sci., 358, 879–883 (2003).
- 5) Sprong, H., Degroote, S., Claessens, T., van Drunen, J., Oorschot, V., Westerink, B. H., Hirabayashi, Y., Klumperman, J., van der Sluijs, P., and van Meer, G., Glycosphingolipids are required for sorting melanosomal proteins in the Golgi complex. J. Cell. Biol., 155, 369–380 (2001).
- 6) Cox, T. M., Aerts, J. M., Andria, G., Beck, M., Belmatoug, N., Bembi, B., Chertkoff, R., vom Dahl, S., Elstein, D., Erikson, A., Giralt, M., Heitner, R., Hollak, C., Hrebicek, M., Lewis, S., Mehta, A., Pastores, G. M., Rolfs, A., Miranda, M. C., and Zimran, A., The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement. J. Inherit. Metab. Dis., 26, 513–526 (2003).
- 7) Kok, J. W., and Sietsma, H., Sphingolipid metabolism enzymes as targets for anticancer therapy. Curr. Drug Targets, 5, 375–382 (2004).
- 8) Reynolds, C. P., Maurer, B. J., and Kolesnick, R. N., Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Lett., 206, 169–180 (2004).
- 9) Platt, F. M., Neises, G. R., Dwek, R. A., and Butters, T. D., N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis. J. Biol. Chem., 269, 8362–8365 (1994).
- 10) Radin, N. S., Shayman, J. A., and Inokuchi, J., Metabolic effects of inhibiting glucosylceramide synthesis with PDMP and other substances. Adv. Lipid Res., 26, 183–213 (1993).
- 11) Lee, L., Abe, A., and Shayman, J. A., Improved inhibitors of glucosylceramide synthase. J. Biol. Chem., 274, 14662–14669 (1999).
- 12) Couto, A. S., Caffaro, C., Uhrig, M. L., Kimura, E., Peres, V. J., Merino, E. F., Katzin, A. M., Nishioka, M., Nonami, H., and Erra-Balsells, R., Glycosphingolipids in Plasmodium falciparum: presence of an active glucosylceramide synthase. Eur. J. Biochem., 271, 2204–2214 (2004).
- 13) Levery, S. B., Momany, M., Lindsey, R., Toledo, M. S., Shayman, J. A., Fuller, M., Brooks, K., Doong, R. L., Straus, A. H., and Takahashi, H. K., Disruption of the glucosylceramide biosynthetic pathway in Aspergillus nidulans and Aspergillus fumigatus by inhibitors of UDP-Glc:ceramide glucosyltransferase strongly affects spore germination, cell cycle, and hyphal growth. FEBS Lett., 525, 59–64 (2002).
- 14) Slavish, J. P., Friel, D. K., Oland, L. A., and Polt, R., New PDMP analogues inhibit process outgrowth in an insect cell line. Bioorg. Med. Chem. Lett., 14, 1487–1490 (2004).
- 15) Leipelt, M., Warnecke, D., Zähringer, U., Ott, C., Müller, F., Hube, B., and Heinz, E., Glucosylceramide synthases, a gene family responsible for the biosynthesis of glucosphingolipids in animals, plants, and fungi. J. Biol. Chem., 276, 33621–33629 (2001).
- 16) Hillig, I., Leipelt, M., Ott, C., Zähringer, U., Warnecke, D., and Heinz, E., Formation of glucosylceramide and sterol glucoside by a UDP-glucose-dependent glucosylceramide synthase from cotton expressed in Pichia pastoris. FEBS Lett., 553, 365–369 (2003).
Bioscience, Biotechnology, and Biochemistry
Volume 69, 2005 - Issue 9